Registered Number: 1628455 Charity number: 516287 

THE MYTON HOSPICES (A company limited by guarantee) 

TRUSTEES REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 



## THE MYTON HOSPICES (A company limited by guarantee) 

## CONTENTS 


**----- Start of picture text -----**<br>
|||||||
|---|---|---|---|---|---|
|Page|
|Reference and|administrative|details|of the|charity|]|
|Trustees’|report|2-16|
|Independent|auditor's|report|17-19|
|Consolidated|statement|of financial|activities|20|
|Consolidated|Balance Sheet|22|
|Company|Balance|Sheet|23|
|Consolidated|statement|of cash|flows|24|
|Notes|fo the|financial|statements|25-49|

**----- End of picture text -----**<br>




## THE MYTON HOSPICES (A company limited by guarantee) 

## REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2024 

Trustees Mr K W Demian, Chairman Dr V Robson Mrs N Virani-Bland (resigned 2 January 2024) Mr J Asbury Mrs S Faulkner Mr M Iredale Dr M Cable (resigned 22 May 2024) Dr C F de Nahlik Mrs K Mascia (appointed 22 November 2023, resigned 12 May 2024) Mr | Huke (appointed 22 November 2023) Mrs A Warhaftig (appointed 22 November 2023) 

Company registered number 1628455 

Charity registered number 516287 

Registered office , Myton Lane, Warwick, CV34 6PX 

## Chief executive officer 

Mrs R Freeman 

## Senior management team 

Mrs R Freeman, Chief Executive Dr S MacLaran, Medical Director and Consultant in Palliative Care (resigned 30' June 2024) Mrs M Linnane, Director of Nursing, Care and Service Development (resigned 30th June 2024) Mr S Jones, Director of Finance and Commercial Development (resigned 31 March 2024) Mr C Thomas, Director of Finance and Facilities (appointed 1 May 2024) Mr D Pratt, Director of Corporate Resources (resigned 31st May 2024) Miss C Ingram, Director of Income Generation and Supporter Development Mrs L Jackson, Director of People Services 

## Independent auditor 

Harrison, Beale and Owen Limited, Highdown House, Leamington Spa, CV31 1XT 

## Bankers 

Lloyds Bank Pic, High Street, Coventry, CV1 5RA 

## Solicitors 

Wright Hassall, Olympus Avenue, Leamington Spa, CV34 6BF 

Investment Managers Evelyn Partners, 103 Colmore Row, Birmingham, B3 3AG 

1 



## THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES' REPORT 

## FOR THE YEAR ENDED 31 MARCH 2024 

The Trustees (who are also directors of the charity for the purposes of the Companies Act) present their annual report together with the audited financial statements of The Myton Hospices (the company and the group) for the year 1 April 2023 to 31 March 2024. 

The Trustees confirm that the annual report and financial statements of the company and the group comply with the current statutory requirements, the requirements of the company and the group's governing document and the provisions of the Statement of Recommended Practice (SORP), applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). The Trustees have complied with the duty in the Charities Act 2011, to have due regard to public benefit guidance published by the Charity Commission. 

## Objectives and Activities 

## a. POLICIES AND OBJECTIVES 

## Our Vision 

The Myton Hospices believe everyone across Coventry and Warwickshire should live well towards the end of their life and have the right to a good, natural death, the way they want it to be, where they want it to be, and with their loved ones supported. 

## Our Mission 

The Myton team provide high quality specialist care to people whose condition no longer responds to curative treatment, from diagnosis to death. We aim to meet their physical, psychological, spiritual and social needs and ensure their families are supported both through and after this difficult time. We are also committed to training, supporting and encouraging other care providers to practise good pailiative care. 

## b. STRATEGY FOR ACHIEVING OBJECTIVES 

Our strategy for 2023-2026 is aligned to the National Ambition Framework for Palliative and End of Life Care, and focuses on five key priorities: 

- e Community e Families e Beds e Influence and Education e Resilience 

## c. ACTIVITIES FOR ACHIEVING OBJECTIVES 

## Our services 

Care and support for our patients and their families is currently delivered in the following ways: 

- e 12 bedded inpatient unit at Warwick Myton Hospice. e 19 bedded inpatient unit at Coventry Myton Hospice. e 24/7 Hospice at Home team covering the Rugby, Warwick & Leamington Spa areas e Counselling Service operating across all 3 sites. e Lymphoedema Service, mainly for those with secondary disease due to cancer, living within Coventry and Warwickshire. 

- e Complementary Therapy service operating across all three sites. 

2 



THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

- e Physiotherapy and Occupational Therapy services, including outpatient services, operating across all three sites. 

- e Spiritual support across all three sites. e Wellbeing Services across all three sites. e Living Well Service across all three sites. e Fatigue and Breathlessness Programme (FA8) across all three sites. 

Having emerged from the pandemic a stronger, leaner more efficient organisation, our aim now is to sustain the services patients tell us they need, innovate to extend reach, and work in partnership to improve outcomes for patients and families. 

Having committed to substantially increasing bed space, the greatest challenges remain around recruiting sufficient staff to care for our patients, and generating sufficient income to fulfil our ambition. Trustees and the executive committed to a budget that would ensure return to full activity levels. The hard work of our staff and volunteers supported financially by hundreds of individual donors and organisations ensured that the charity maintained plentiful reserves to underpin our ambitious plans. Our Fundraising, Lottery and Retail teams continue to perform extremely well providing over 80% of the funds needed to support the work of the organisation. 

## Our Strategy 

Commencing in April 2023, our 3 year strategy focuses on reaching people earlier in their illness and being alongside them every step of the way by maintaining the services that patients and families tell us they need, looking at innovative ways to extend reach and working in partnership with others who share our commitment to caring for people with palliative and end of life care needs. The areas of priority are our work in the community, In-patient beds, support for families and carers, our influence and Education programmes and remaining resilient, 

## Community 

Coventry and Warwickshire patients living with a terminal illness and their loved ones, should have access to the right information and advice from the moment they are told their illness cannot be cured. They should be able to receive high quality care and support in their homes and in the community when they need it. The needs of different individuals and communities must be considered and services designed to meet them. Patients whose preference is to die at home should have their symptoms and their pain better controlled so that admission into hospital can be avoided. 

In three years Myton will have expanded our services within the community to enable and encourage more people to access them as early as possible by: 

- e Engaging with local people and communities to increase our presence, visibility, and awareness of the services we and others provide. 

- e Facilitating Palliative and End of Life Care information services through Myton’s community hubs. 

- e Introducing a 24/7 Patient and Care Helpline, staffed by trained Palliative Care specialists. e Delivering our Wellbeing and Carer Support Services in the community as well as in our hospices. 

- e Taking an innovative approach to extending reach by maximising the opportunities offered by digital platforms. 

- e Employing more Registered Nurses in our Myton at Home team so that more patients whose preference is fo die at home can do so with their pain and symptoms better controlled. 

3 



## THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES’ REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

## Families 

The families and carers of patients with Palliative and End of Life Care needs are fundamental to their outcomes. Providing the right help for them impacts not only on their health and resilience but also on their ability to support the patient. They should have access to advice and support that will help them cope so they can play the part they want to in caring for their loved ones. 

In three years Myton will have ensured that more families and carers are supported to cope and care for themselves and their loved ones by: 

- e Developing a range of support and advice services for carers and families. e Integrating our bereavement services and opening them up for all wno need them. e Developing a team of volunteers to provide practical support for carers and families. e Working with partners to provide financial planning and advice. e Working in collaboration with local partners to provide more post bereavement support networks. 

## Beds 

Patients with complex needs should have access to specialist Palliative Care beds when they need them. Patients approaching the end of life should have access to a bed supported by staff trained in Palliative and end of Life Care both inside and outside of the hospice. This is necessary to meet current and predicted demand and to ensure that patients dying in hospital who would prefer to die in a hospice have access to a hospice bed. Patients and families needing respite should have access to Respite beds. 

- In three years Myton will have improved access to Myton supported Palliative Care beds by: e Achieving better utilisation of our inpatient beds by adopting a model which supports routine admissions seven days a week. 

   - e Re-introducing Respite beds. e Having a clinical model which enables a flexible approach to bed management. e Working with and supporting partners to provide a network of Palliative Care beds outside of the hospice. 

## Influence and Education 

Referrers and healthcare professionals need to know what Palliative and End of life Care is available and the benefits of being referred early. There needs to be more hospice supported beds in the community and they should be provided by trained Palliative Care clinicians. The patient and carers view should be the biggest influence in the design of the services they need and their voices must be heard. As experts in specialist Palliative and End of life Care we will use our knowledge and expertise to influence the debate about death and dying and to shape the wider Palliative and End of Life Care strategy. 

In three years Myton will have positively influenced the experience of patients with Palliative and End of life Care needs and will lead strategic work by:- 

- e Being recognised for the outstanding care we provide. e Seeking out and working with partners aligned to our ambition to improve End of Life Care services. 

- e Further developing our internal and external education programmes. e Facilitating more conversations about death and dying. 

- e Working with patients, carers and the public to hear their views and translating them into service design and advocacy. 

4 



## THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES’ REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

- e Running consistent public information campaigns so that the public, carers and healthcare professionals know what services we offer, how to access them and their benefits. 

- e Educating other healthcare professionals to provide Palliative and End of Life Care across a range of settings in the community. 

## Resilience 

Myton must protect its workforce, infrastructure and finances so that services for patients and families are secure for the future. It is vital that negotiations with funders and supporters remain a priority so that we can continually improve across all areas of our business, so that all services result in the very best outcomes for patients and remain excellent value. With hard-pressed resources it is essential to work in partnership to achieve the maximum benefit for patients and families, whilst ensuring we maintain our unique identity and strong brand. 

In three years Myton will continue to be a financially strong organisation, ensuring that our workforce, infrastructure and finances achieve the optimum benefit for patients and families by: 

- e Increasing the proportion of our income that is guaranteed and ensuring each service is giving optimum value to patients and families. 

- e Investing in our voluntary income operation. 

- e Reviewing the workforce model and ensuring that staff feel valued and have the skills to meet the needs of the organisation. 

- e Developing our volunteer workforce. 

- e Having accessible buildings that meet the needs of patients, families, and our staff and volunteers. 

- e Being more environmentally sustainable. e Working in partnership with the NHS and other healthcare and voluntary organisations to optimise shared skills, expertise and resources. 

## d. MAIN ACTIVITIES UNDERTAKEN TO FURTHER THE CHARITY'S PURPOSES FOR PUBLIC BENEFIT 

Our Charitable activities are focused on offering free care and support to patients and their families from the moment they receive a diagnosis that their illness is incurable. Referrals are accepted from a variety of sources and places allocated according to clinical need. We work Closely with a range of health care professionals to ensure that the maximum benefits for the patients and the people that love them are achieved. 

## STRATEGIC REPORT 

## Achievements and performance 

## a. REVIEW OF ACTIVITIES 

## In Patient Services 

Reopening more beds required a huge collective effort from our clinical, medical and people teams, significantly hindered by a tough staff recruitment environment, with many patient care organisations competing for a scarce pool of nursing staff. Implementing innovative ways of attracting staff proved successful, although the continuing lack of financial support from the NHS for nationally recognised cost pressures does have a longer-term impact on our ability to achieve ambitious future expansion plans. The proportion of commissioned income once again fell marginally as a percentage of total revenues to 21.9%. 

5 



## THE MYTON HOSPICES (A company limited by guarantee) TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

Increased efforts from the Myton team sawa significant increase in the number of patients admitted to our IPUs compared to the previous year, rising from 549 in 2022/23 to 604 in 2023/24, an increase of 10% year on year. Overall bed occupancy rose considerably, from 86% in 2022/23 to 83% in 2023/24. We are also very pleased with the way in which our supplemented provision for inpatients and their families through our welfare team and others, continues to ensure a more comprehensive package of care when patients and their loved ones most need it. 

## Myton at Home 

The service continues to deliver care in a person's own home working alongside the district nurses (DN's) and General Practitioners (GP's). The addition of Clinical Nurse Practitioners continues to further enhance the service, and during 23/24 The Myton at Home team supported 156 patients, unchanged from the previous year, but total home visits for patients across Coventry & Warwickshire in 2023/24 rose by 18% to 3,249 compared to the prior year figure of 2,746, illustrating a substantial increase in the number of visits achieved for each patient cared for. 

## Lymphoedema 

During the year our Lymphoedema service continued to grow its support of patients referred to Myton from South Warwickshire Foundation Trust and University Hospital Coventry and Warwickshire, as well as to our own patients. 594 patients were supported by the Lymphoedema feam (667 in 2022/23). 

The Hospice has Service Level Agreements with the two NHS trusts, and attracts an income based on the number of patients treated. 

## b. ACHIEVEMENTS 

Myton has emerged from the pandemic a stronger organisation, entirely due to the incredible hard work and commitment of the entire Myton community, led by the frontline staff and leadership teams, complete with the phenomenal goodwill and support of our donors, supporters and volunteers. The exceptional work delivered by everyone during the pandemic continued into 2023/24 against a backdrop of continuing restrictions in NHS funding, a tough environment in which to raise voluntary income, difficulties in recruiting key staff. especially nurses, and escalating cost pressures. Despite this we continue to operate at above pre-pandemic service levels. Total individuals supported in 23/24 was 1,965 an uplift of 14.3 % on the previous year and 18.8 % on 19/20 immediately prior to the Pandemic. Within this increase, patient numbers rose by 14.2% and family members rose by 14.6%. 

## c. VOLUNTARY INCOME 

With only around 1/5'h of total funds received coming from NHS commissioners, voluntary income holds the key to the successful operations of Myton. This is achieved across three principal areas, Fundraising (inc. Legacy), Lottery and Retail. Our Income Generation teams supported by the local community generated a superb total of £9.73m gross (net £5.95m), an extraordinary effort in the present economic conditions. 

Together, Retail and Lottery generated over £5.2m gross, contributing £2.33m towards delivering our objectives. Continuing this performance will be critical to the overall success of the charity, and with bold expansion plans within the new three year strategy, expectations are high that we will maintain and hopefully exceed these numbers in future. 

6 



THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES’ REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

In summary the net revenue generated from voluntary income of £5.95m equates to 2.1 times the amount received from NHS commissioned income, with the gross sums of £9.73m a whopping 3.5 times that funded by the NHS. 

## Our fundraising standards: 

The Myton Hospices are members of the Fundraising Regulator, and we abide by their Fundraising Code of Practice which covers various aspects of fundraising. We work tirelessly to protect our supporters’ data, as well as evolving our systems to ensure that our supporters can choose how they would like to be contacted and with what types of communication, in compliance with the General Data Protection Regulations. For all mailings / campaigns we have a dedicated team of staff who provide the mailing lists and an electronic process that must be completed by the member of staff arranging the mailing. Data requests must include the following; name of mailing, communication type, audience targeted and rationale behind each person receiving this communication. All of this data is stored and we have a clear audit trail that can be referred back to as and when it is required. We have an Income Generation Policy and also an Ethical Fundraising Policy and we ensure that everyone is working within these guidelines at all times. We also comply with the Gambling Commission and adhere to all of the associated codes of practice relating to our lottery promotion and indeed the operating of our weekly lottery. 

Lottery canvassing is performed by an internal team of our own staff, and also external contractors. The staff receive an in-depth induction when they join Myton to ensure that their standards and practises when dealing with the public are to the highest standard. The performance and practices of external lottery canvassing teams are also monitored, in order to ensure that those teams represent the Hospice to the standards expected. Staff employed by the external companies will also visit the Hospice and undertake training from our lottery team. All complaints relating to the Lottery service are referred to the Chief Executive Officer who will then delegate the responsibility of investigation to either the Director of Income Generation or the Lottery Manager. The Director of Income Generation and the Lottery Manager ensure that they are responded to in an appropriate manner. 

## Monitoring our fundraising: 

We monitor our fundraisers and lottery canvassers' practices carefully. All supporter calls, emails and letters are logged with summaries and key issues communicated back to the management team to improve future communications. We have a complaints policy that is adhered to for all complaints received and any issue is escalated to the CEO. Each issue is then investigated and the supporter is responded to accordingly. We're very aware of the potential of fundraising to become persistent or intrusive. We have established internal standards to guide how often we contact supporters and provide clear and simple ways for them to opt out of future communications. We ask supporters for feedback on this issue and continue to monitor the issue closely. During the financial year x complaints were received and responded to. These complaints include feedback around lottery canvassers and our lottery in general, information being sent to a supporter, or negative comments received following a fundraising activity or through an incident in one of our 26 shops or via our collections service. 

Our external fundraising companies have a comprehensive Myton induction before a canvasser represents Myton and we ensure they all have of the correct Myton information with them and represent Myton in an honest and open way at all times and adhere to our mission and values and behaviours. We arrange spot checks to ensure this is being undertaken and we act swiftly if Myton is not represented correctly. We have established a policy to help us identify potentially vulnerable people and we adhere to all regulations prescribed by the Gambling Commission and Fundraising Regulator. With our lottery promotion, we ensure that all of our supporters are 

7 



THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES’ REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

fully understanding of our lottery ask and if we are ever concerned that an individual may be vulnerable, we would apply follow up communications to ensure the individual was happy with an agreement before any payment is taken. We have a responsibility to ensure each entrant must be at least 16 years of age. 

## d. INVESTMENT POLICY AND PERFORMANCE 

The value of investments is £4,867,041(2022/23 - £4,586,399). This balance is held in a long term investment portfolio managed by Brewin Dolphin, the returns on the investments during the year are paid as income to the charity. Following a market testing exercise during the year, it was agreed to move the management of this investment portfolio from Brewin Dolphin to Evelyn Partners, and this process had just commenced as at 315! March 2024. The Myton Hospices also shows investments in subsidiaries of £45,354 on its own balance sheet. 

The charities reserve policy states that the reserves balance is held in investments. When the cash balances of the organisation are above the levels needed in working capital, the Finance and Audit Committee agree to move more funds into investments to ensure the best rate of return is generated. Owing to unrealised losses in the holding value of investments during the highly volatile pandemic period, for the time being, cash reserves have been consciously maintained to protect the capital value of the excess of reserves over policy requirements. 

## Financial review 

## Q. 2023-24 FINANCIAL PERFORMANCE 

The Charity's Management Board agreed an operating deficit budget of £215k before investment gains/losses for the year 2023/24, a net surplus budget prior to depreciation of £243k. Despite excellent performances in the Fundraising and Retail functions of the charity, Myton has found itself in a tough operating environment this year with cost pressures of ifs own as well as the impact of the cost-of-living crisis on its voluntary income. Myton therefore recorded a net loss before investment gains/losses of £689,145 (2022/23 — loss £4,470). The cash deficit falls to £231,926 (2022/23 — surplus £326,696) once depreciation is added back. The overall decrease in funds, arrived at by subtracting investment losses from operating loss is £312,708 (2022/23 — decrease £299,333). Given the circumstances, the trustees are proud of the financial performance of the charity, whilst also recognising the significant challenges that lie ahead. 

## income 

NHS Grant Income 

NHS Grants increased by 1.69% overall in 2023/24 to £2,695,681 from £2,649,905 in 2022/23, with growth in Lymphoedema demand and additional funding for nurse led beds adding to the 1.7% cost of living increase applied to each of the previous year's service level agreements. 

There are four elements to the NHS funding, the main block contracts; Coventry and Warwickshire ICB (CWICB), South Warwickshire NHS Foundation Trust (SWFT), the Myfon at Home contract for the service in the Rugby area (CWICB), the Nurse Led Bed contract which commenced in November 2015 (SWFT) and Lymphoedema treatment services provided to the ICB. 

8 



## THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

## Donations and Legacies 

During 2023/24 income from donations and legacies totalled £5,005,880, a 12.73% increase on the previous year (2022/23 - £4,440,744). Legacies left to the hospice in 2023/24 were £1,437,604, a 13.3% increase on the prior year (2022/23 - £1,269,289). Donations saw an increase year on year with a total of £3,568,276 being donated by our supporters (2022/23 - £3,171,455). 

## Trading Company Income (Myton Hospice Promotions Limited) 

Retail has found itself in the same tough overall environment as our other sources of voluntary income, but maintained a strong position throughout the year. Gross income was up 5% at £2,755,149 but net income fell by 9% to £792,641 

Whilst this was an excellent result overall, it does highlight the impact of cost pressures over the course of the year. Each of Myton’s 26 shops is profitable and the coming year will see action taken on costs to manage the impact of their increases and maximise the contribution made to Myton's overall funds. 

Gross income from Lottery in 2023/24 was £2,057,931 (2022/23 - £2,261,103) and continues to contribute strongly to our overall income. Retention and stability are key performance measures, which are illustrated by a fall of 893 lines year on year, to 37,400 (38,293 in 2022/23) at the end of March 2024, 

Net contribution from the Lottery saw an increase year on year, contributing £1,538,061 to overall charitable performance, around £76k more than the previous year. In a very competitive sector of charity / society lotteries, Myton still maintains the largest single hospice lottery in the UK. 

In total the trading company gift-aided £1,059,723 to the charity (£1,234,646 in 2022/23). 

## Direct Costs of Patient Care 

Direct costs of patient care totalled £8,490,045 (2022/23 - £7,561,931), an increase of 12.2%, and a further sign of the cost pressures facing Myton when compared to the much smaller increases in NHS contractual income. 

## Indirect Patient Care Costs 

With a continuing focus on efficiency measures, total indirect costs continued to be managed tightly in the year. The totals were £1,260,119 (2022/23 - £1,206,062) a 4.5% increase on the prior year. 

## Total Funds 

At the year end, the total funds of the group stood at £14,868, 126 (2022/23 - £15,160,834) including restricted funds which totalled £173,505 (2022/23 - £189,440). 

## b. GOING CONCERN 

After making appropriate enquiries, the trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the Accounting Policies. 

9 



## THE MYTON HOSPICES 

## (A company limited by guarantee) 

## TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

## c. PRINCIPAL RISKS AND UNCERTAINTIES 

A tisk register for the charity is maintained and reviewed by the Trustees at each quarterly subcommittee and then at each Board meeting. Currently the top five corporate risks are as follows: 

1. Voluntary income in the coming year. The continuing trend of NHS grant funding failing to keep pace with inflation increases our reliance on the generosity of our donors and supporters, with voluntary income making up almost 80% of total income. We need to be confident that we can rely on the generous support of our donor base. High inflation, the continuing cost of living crisis and the ongoing conflict in Ukraine means donors pockets could potentially be less deep until the economy fully recovers. Our fundraising, retail and lottery teams are well resourced and continue to defy concerns but trustees are rightly concerned that any downturn in the economic environment would have an immediate impact on performance and reserves. 

2. Staff burnout. Hospice work caries some innate risk to the psychological and emotional wellbeing of staff. This can be exacerbated by the complex needs of the patients we care for and the operational challenges of accessing the sources of on-site, telephone based and on-line emotional support we provide. There is a risk of stress, depression anxiety and work-related absences, which can increase with higher patient numbers and when staffing is already impacted by other absences. In turn, this then presents a risk to the additional funding received to keep more beds open. 

3. Unmet demand. This presents a risk to patients of not dying in their preferred place and increases the reputational risk to Myton. If could also impact upon the negotiations currently ongoing about increased funding for beds in particular 

- 4, NHS pay awards. When it was made in 2024 the latest NHS Pay Award was confirmed as higher than Myton’s own Pay Award, and it is considered likely that this trend will continue. When combined with continuing high inflation starting to drive higher salary demands, this contributes heavily to the cost pressures on Myton. There is a risk to recruitment and retention across several teams from Myton pay falling behind competitors. 

5. Staffing levels in our inpatient units. Combination of sickness absence and ongoing vacancies levels could impact on our ability to maintain safe nurse staffing numbers within our inpatient units, with the potential impact on unmet demand, Myton's reputation and patient welfare. 

## d. RESERVES POLICY 

The reserves policy of four months, or around £4m running costs continues. The funds are held in a long-term, medium risk investment portfolio. Additional reserves are held for the purpose of a future Estates Strategy and other innovation projects to grow service provision, with funds allocated througha series of designated funds. 

Total funds of the group at the year-end stood at £14,848,126 (2022/23 - £15,160,834). Restricted funds totalled £173,505 (2022/23 - £189,440) and unrestricted funds totalled £14,674,621 (2022/23 - £14,97 1,394). Free reserves of the group at the year end, stood at £300,157 (2022/23 — 936,490). 

10 



THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

Designated funds totalled £14,374,464 (2022/23 - £14,034,904) which is made up of the following funds: 

- e fixed asset fund of £7,483,543 (2022/23 - £7,213,278), e investment fund of £4,867,041 (2022/23 - £4,586,399), e the service expansion fund of £116,634 (2022/23 - £116,679) and the Warwick hospice improvements fund of £500,000 (2022/23 - £500,000). 

Further designated funds also remain agreed as project funds for projects that the trust board have agreed will help the sustainability of the organisation financially and will extend the reach of the Hospice to those who are currently unable to access Hospice services: 

- e Hospice outside of the walls project £452,050 e Digital strategy and transformation project £96,370 e Innovation Fund £858,826 

The assets representing each of these funds are analysed in Note 22 to the financial statements. 

## e. PRINCIPAL FUNDING 

The Hospice is aware that the commissioning of end of life services across Coventry and Warwickshire is likely to change in the coming years as ICBs and NHS Trusts work collaboratively to commission services. Myton is ensuring ifs presence in these commissioning rounds and working to protect and grow this valuable income. 

Myton is also working collaboratively with other healthcare organisations and hospices to offer commissioned services where appropriate within the Coventry and Warwickshire area. 

## Structure, governance and management 

## a. CONSTITUTION 

The company and the group is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association on 25th February 2009. The company and the group is constituted under a Memorandum of Association dated 25th February 2009 and is a registered charity number 516287. The principal object of the company and the group is to provide care to patients and their families in the Coventry and Warwickshire area, from the time that they receive the diagnosis that their illness is incurable. On November 16!» 2022 a special resolution was adopted by trustees introducing modified articles of association, the primary changes being the introduction of a winding up clause and the removal of a clause capping the number of trustees at twelve. Fuller details of the structure are set out below. 

## b. METHOD OF APPOINTMENT OR ELECTION OF TRUSTEES 

The Board of the Myton Hospices is made up of not less than 4 Trustees, of which 2 of the roles must be medical representatives. All Trustees are appointed for an initial period of three years, commencing with the first Annual General Meeting following their appointment and may apply for re-election to serve up to three terms, each of which is a period of three years. After serving a third period, the Director must step down, but may offer him/herself for re-election after a period of twelve months. 

11 



## THE MYTON HOSPICES (A company limited by guarantee) TRUSTEES’ REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

All Trustees are registered volunteers, recognised as Directors of The Myton Hospices on the Companies' House records and members of the charity. The Board is ultimately responsible for Myton Hospices care, finances, buildings and compliance. The Trustee Board are accountable to the Care Quality Commission, Companies House, the Gambling Commission, and the Charity Commission for their activities and those of the hospices related. 

## c. POLICIES ADOPTED FOR THE INDUCTION AND TRAINING OF TRUSTEES 

Trustees are provided with a programme of induction including meeting with all of the executive team and any other key personnel in order to gauge an understanding of how the hospice works on a day to day basis. Trustees are encouraged to spend time within the clinical areas of the hospice, and to attend fundraising events. 

## d. PAY POLICY FOR SENIOR STAFF 

Working in the Charity sector Myton believes that it is important to be transparent about the pay levels of its senior managers and how those salaries are set. Our salaries are benchmarked against similar roles in the Midlands charity sector using an external independent UK salary database. For all roles, including senior posts, Myton's pay strategy is for salaries to be between the lower and median quartiles for equivalent positions. with some flexibility applied to take into consideration the specific requirements for each post and to ensure that we can recruit and retain the best people for the role with both the skills required and the passion for the service. 

## Our executive team is made up of the following roles: 

Chief Executive Officer 

Director of Patient and Family Services Director of Finance and Facilities Director of People Services Director of Voluntary Income and Supporter Development 

The total annual costs during 2023/24 of the Senior Leadership Team who are employed by Myton are £508,000 pa (net of NI and pension costs) (2022/23 - £502,000 pa). 

## e. ORGANISATIONAL STRUCTURE AND DECISION MAKING 

There are clear distinctions between the roles of Trustees and the executive team. The board of trustees holds a range of reserved matters and delegates certain authority to the executive team in order to run the organisation efficiently. Matters such as policy, strategy and budgets are prepared by the executive team for consideration and approval by the trustees who then monitor the implementation of these plans. There are a number of board committees, all with clear terms of reference. They have elected members of both the board of trustees and the executive team who have been selected for their particular skills, experience and knowledge. Committee's meet at least once per quarter and report into the main board meetings. 

During the year the committees operated are as follows: 

- e Clinical Governance Committee, which is responsible for patient care, safety, activity and quality. 

- e Finance and Audit Committee, which monitors the Charity's financial position. 

12 



## THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES’ REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

- e The People and Resources Committee, this committee is responsible for staff wellbeing, recruitment and retention, and training as well as information governance and estates 

- e The Appointment and Remuneration Committee, which oversees the appointment of trustees, Chief Executive Officer and Company Secretary, and remuneration issues as appropriate. 

## Charity Governance Code 

The trustees are aware of the new guidance and a governance review was undertaken to assess the charity's compliance with the guidelines. The code was a key reference point during a review of governance, including the adoption of new articles of association in the year, and a wholesale review of underpinning governance procedures undertaken during the year. A new scheme was developed for implementation from April 2023, improving and simplifying governance. 

## f. RISK MANAGEMENT 

The Hospice is committed to effective risk management as an integral part of ensuring good corporate governance. Risk can be to patients and relatives, staff, financial or reputational. The executive team have recognised a need for ongoing management of risks to the organisation. When risks are identified they are allocated to a member of the executive team, and that team member becomes responsible for identifying actions to be taken to mitigate the risk. 

Each governing committee reviews the risks associated with their area of expertise. As trustees, the board concentrates its efforts on ensuring the most serious risks are being managed effectively. The Hospice continues to improve and refine the risk management processes. As identified in the Principal Risks and Uncertainties section of this report, the top five risks for the Hospice at the 31st March 2024 are as follows: 

1. Voluntary income in the coming year. 2. Staff burnout. 3. Unmet demand. 

- 4, NHS pay awards 

5. Staffing levels in our inpatient units. 

The Trustees have assessed the major risks to which the company and the group is exposed, in particular those related to the operations and finances of the company and the group and are satisfied that systems and procedures are in place to mitigate our exposure to the major risks. 

## g. TRUSTEES’ INDEMNITIES 

Qualifying third party indemnity provision is in place for the benefit of all Trustees of the charitable company. This cover is up to £1,000,000 and costs £9,240. 

## FUTURE DEVELOPMENTS 

The year to 31st March 2024 saw Myton working to the first year of it's new strategy covering the period from 2023 to 2026. Details of this strategy are set out earlier in this Trustees Report, and cover all currently planned future developments for Myton. 

13 



## THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES’ REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

## The overarching aims can be summarised under the headline; 

To reach more people earlier in their illness and be with them and their families every step of the way 

## Governance 

Following the introduction of a new governing document in 2022/23 and in preparation for the new three strategy, trustees set about preparing a new underpinning governance framework to optimise support to the executive team. An overly burdensome sub-committee structure was seen as a contributory factor to sub-optimal executive capacity, with a need to free up management time to deliver the bold and ambitious expansion plans set out in the new strategy. From April 2023 the new scheme of management took effect, with streamlined quarterly meetings in place, providing more time for the CEO and senior team to enhance patient care, reaching more patients, sooner in their journey, including more support for families and friends. 

## Innovation 

With strong patient and family care and support already emphatically being delivered despite the challenging economic landscape, the emphasis on future development requires a more innovative approach, in order to extend our reach and influence. With this in mind Trustees are seeking to maximise our strong reserves position, and allocated a designated fund of £1m, for the executive team to explore imaginative new ways to support the local community. From this fund, £141,174 has so far been spent, leaving a balance of £858,826 still to be used. 

## Equality, Diversity & Inclusion 

The Myton Hospices is dedicated to enhancing diversity and inclusivity amongst staff, volunteers, patients and families, as well as ensuring equitable access for those not yet utilising our services. Through research we have identified a number of underrepresented groups in our community and held focus groups to explore potential barriers for people affected by poverty and homelessness, Asian communities and those in rural areas. Through collaborations with 50+ organisations, we are increasing our understanding of their needs and developing mutually beneficial partnerships to aid equity of access and enhance our service provision for all. 

## Development, Reach and Growth 

In practice our strategy hinges on the provision of extra service, extra reach and generating the financial means to achieve them. Returning to the bed provision of 35 beds across our 2 inpatient units remains critical despite the current funding issues, as is ensuring more home visits to patients and broadening access to more of our services such as wellbeing, therapies, respite care and lymphoedema treatment. Creating improved access to advice and guidance for patients and families, earlier in their illness is also seen as critical to the success of the strategy. 

Away from patient care, expansion of our charity shops portfolio, improved negotiations for core NHS contracts and maintaining/growing our excellent lottery will be vital to continued success. We need to find new imaginative ways for our existing and new donors to support Myton. Our people function will continue to evolve, particularly as we increase our efforts to ensure that we cater for the full spectrum of stakeholders in Coventry & Warwickshire, through employment, volunteering and governance, in addition to wider patient reach. 

14 



## THE MYTON HOSPICES (A company limited by guarantee) TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

Complacency is the enemy of progress, with everyone at Myton totally committed to ensuring that we not only continue to excel at everything we are already known for, but also that we thrive in future, making Myton an even more successful charity than has proved to be the case for over 40 years. Our patients, families, benefactors, staff, volunteers and trustees deserve no less. 

## FUNDS HELD AS CUSTODIAN 

The Charity acts as an agent in administering funds for "GP PMS Education” on behalf of the NHS. An amount of £11,057 (2022/23 - £11,269) is included in other creditors relating to undistributed funds. 

## PEOPLE WITH DISABILITIES 

Employees have been consulted on issues of concern to them by means of regular consultative committee and staff meetings and have been kept informed on specific matters directly by management. The company and the group carries out exit interviews for all staff leaving the organisation and has adopted a procedure of upward feedback for senior management and the Trustees. 

The company and the group have implemented a number of detailed policies in relation to all aspects of personnel matters including: 

## ° Equality, Diversity & Inclusion (EDI) policy 

- ° Volunteers’ policy ° Health & safety policy 

In accordance with the company and the group's EDI Policy, the company and the group have long established fair employment practices in the recruitment, selection, retention and training of disabled staff. 

Full details of these policies are available from the company and the group's offices. 

## TRUSTEES’ RESPONSIBILITIES STATEMENT 

The Trustees (who are also directors of The Myton Hospices for the purposes of company law) are responsible for preparing the Trustees’ report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). 

Company law requires the Trustees to prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and the group and of the incoming resources and application of resources, including the income and expenditure, of the charitable group for that period. In preparing these financial statements, the Trustees are required to: 

- ° select suitable accounting policies; and then apply them consistently; ° observe the methods and principles in the Charities SORP; ° make judgments and accounting estimates that are reasonable and prudent: ° prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable group will continue in operation. 

15 



## THE MYTON HOSPICES (A company limited by guarantee) 

## TRUSTEES' REPORT (continued) FOR THE YEAR ENDED 31 MARCH 2024 

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company and the group's transactions and disclose with reasonable accuracy at any time the financial position of the charitable group and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

## DISCLOSURE OF INFORMATION TO AUDITOR 

Each of the persons who are Trustees at the time when this Trustees’ report is approved has confirmed that: 

- ° so far as that Trustee is aware, there is no relevant audit information of which the charitable group's auditor is unaware, and 

- . that Trustee has taken all the steps that ought to have been taken as a Trustee in order to be aware of any relevant audit information and to establish that the charitable group's auditor is aware of that information. 

This report was approved by the Trustees, on 21 August 2024 and signed on their behalf by: 

Mr K W Demian Chairman 

16 



## THE MYTON HOSPICES (A company limited by guarantee) 

## INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE MYTON HOSPICES 

## OPINION 

We have audited the financial statements of The Myton Hospices (the ‘parent charity’) and its subsidiaries (the 'group') for the year ended 31 March 2024 set out on pages 21 to 51. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’. 

- In our opinion the financial statements: ° give a true and fair view of the state of the group's and of the parent charitable company's affairs as at 31 March 2024 and of the group's incoming resources and application of resources, including its income and expenditure for the year then ended; 

- ° have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and . 

- ° have been prepared in accordance with the requirements of the Companies Act 2006. 

## BASIS FOR OPINION 

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. 

## CONCLUSIONS RELATING TO GOING CONCERN 

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate. 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. 

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report. 

## OTHER INFORMATION 

The Trustees are responsible for the other information. The other information comprises the information included in the Annual report, other than the financial statements and our Auditor's report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information we are required to report that fact. We have nothing to report in this regard. 

17 



## THE MYTON HOSPICES (A company limited by guarantee) 

## INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE MYTON HOSPICES 

## OPINION ON OTHER MATTERS PRESCRIBED BY THE COMPANIES ACT 2006 

- In our opinion, based on the work undertaken in the course of the audit: 

- e the information given in the Trustees’ Report for the financial year for which the financial statements are prepared is consistent with the financial statements. 

- . the Trustees’ Report and the Group Strategic Report have been prepared in accordance with applicable legal requirements. 

## MATTERS ON WHICH WE ARE REQUIRED TO REPORT BY EXCEPTION 

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Report. 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion: 

- . the parent charitable company has not kept adequate and sufficient accounting records, or returns adequate for our audit have not been received from branches not visited by us; or 

- ° the parent charitable company financial statements are not in agreement with the accounting records and returns; or 

- ° certain disclosures of Trustees’ remuneration specified by law are not made; or . we have not received all the information and explanations we require for our audit. 

## RESPONSIBILITIES OF TRUSTEES 

As explained more fully in the Trustees’ responsibilities statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. 

In preparing the financial statements, the Trustees are responsible for assessing the group's and the parent charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the group or the parent charitable company or to cease operations, or have no realistic alternative but to do so. 

## AUDITOR'S RESPONSIBILITIES FOR THE AUDIT OF THE FINANCIAL STATEMENTS 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. 

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud is detailed below: 

- Auditing the risk of management overide of controls, including through testing journal entries and other adjustments for appropriateness; 

- « Reviewing minutes of meetings of those charged with governance; and 

18 



## THE MYTON HOSPICES (A company limited by guarantee) 

## INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE MYTON HOSPICES 

- ¢ Enquiry of management to identify any instances of non-compliance with laws and regulations. 

Because of the inherent limitations of an audit, there is a risk that we will not detect all iregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. 

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's report. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. USE OF OUR REPORT This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed. 

Gregg Olner MPhil BA(Hons) FCA (Senior Statutory Auditor) For and on behalf of Harrison Beale & Owen Limited Chartered Accountants and Statutory Auditors Eligible to act as an auditor in terms of Section 1212 of the Companies Act 2006 11 Highdown Road Leamington Spa Warwickshire CV31 1XT 

21 August 2024 

19 



THE MYTON HOSPICES (A company limited by guarantee) 

## CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES INCORPORATING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 MARCH 2024 

||Note|Unrestricted<br>funds<br>2024|Restricted<br>funds<br>2024|Total<br>funds<br>2024|Total<br>funds<br>2023|
|---|---|---|---|---|---|
|||£|£|£|£|
|INCOME FROM:||||||
|Donationsand legacies|3|4,484,386|§21,494|5,005,880|4,523,903|
|Charitable activities|4|2,721,071|-|2,721,071|2,683,990|
|Othertrading activities<br>Investments<br>Otherincome|5<br>6|4,864,435<br>214,308<br>79,608|-<br>-<br>:|4864435<br>214,308<br>79,608|4,921,323<br>130,832<br>19,762|
|TOTALINCOME||12,363,808|521,494|12,885,302|12,279,810|
|EXPENDITURE ON:||||||
|Raising funds:||||||
|Voluntary and trading income|8|3,799,389|-|3,799,389|3,495,496|
|Investment management||24,894|-|24,894|21,061|
|Charitable activities<br>TOTAL EXPENDITURE|7|9,403,113<br>13,227,396|347,051<br>347,051|9,750,164 <br>13,574,447|_8,767,993<br>12,284,550|
|NETINCOME/(EXPENDITURE) BEFORE||||||
|INVESTMENT GAINS/(LOSSES)||(863,588)|174,443|(689,145)|(4,740)|
|Net gains/(losses) on investments||376,437|:|376,437|((294,593}|
|NET INCOME/(EXPENDITURE) BEFORE||(487,151)|174,443|(312,708)|=(299,333)|
|TRANSFERS||||||
|Transfers between funds||190,378|(190,378)|-|-|
|NET INCOME/(EXPENDITURE) BEFORE||||||
|OTHER RECOGNISEDGAINSAND||(296,773)|(15,935)|(312,708)|= (299,333)|
|LOSSES||||||
|NETMOVEMENT IN FUNDS||(296,773)|(15,935)|(312,708)|(299,333)|
|RECONCILIATION OF FUNDS||||||
|Total funds brought forward||14,971,394|189,440|15,160,834|15,460,167|
|TOTALFUNDSCARRIEDFORWARD||14,674,621|173,505|14,848,126|15,160,834|



The notes on page 26 to 51 form part of these financial statements. 

20 



## THE MYTON HOSPICES (A company limited by guarantee) 

## CONSOLIDATED STATEMENT OF FINANCIAL ACTIVITIES INCORPORATING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 MARCH 2023 

|||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|
||Note|funds<br>2023|funds<br>2023|funds<br>2023|funds<br>2022|
|||£|£|£|£|
|INCOME FROM:||||||
|Donationsand legacies|3|4,158,288|365,615|4,523,903|4,693,114|
|Charitable activities|4|2,683,990|-|2,683,990|2,529,077|
|Othertrading activities|5|4,921,323|-|4,921,323|4,262,651|
|Investments|6|130,832|-|130,832|93,321|
|Otherincome||19,762|-|19,762|28,813|
|TOTALINCOME||11,914,195|365,615|12,279,810|11,606,976|
|EXPENDITURE ON:||||||
|Raising funds:||||||
|Voluntary and trading income|8|3,495,496|-|3,495,496|3,015,168|
|Investmentmanagement||21,061|-|21,061|22,697|
|Charitable activities||8,552,613|215,380|_8,767,993 __8,129,149||
|TOTALEXPENDITURE|7|12,069,170|215,380|12,284,550 __11,167,014||
|NETINCOME/(EXPENDITURE) BEFORE||||||
|INVESTMENT GAINS/(LOSSES)||(154,975)|150,235|(4,740)|439,962|
|Net (losses)/gains on investments||(294,593)|-|__(294,593)|163,420|
|NET INCOME/(EXPENDITURE) BEFORE||(449,568)|150,235|(299,333)|603,382|
|TRANSFERS||||||
|Transfersbetween funds||108,620|__(108,620)|-|-|
|NET INCOME/(EXPENDITURE) BEFORE||||||
|OTHER RECOGNISED GAINSAND||(340,948)|41,615|(299,333)|603,382|
|LOSSES||||||
|||,||||
|NETMOVEMENT IN FUNDS||(340,948)|41,615|= (299,333)|603,382|
|RECONCILIATION OF FUNDS||||||
|Total funds brought forward||15,312,342|147,825|15,460,167|14,856,785|
|TOTALFUNDSCARRIEDFORWARD||14,971,394|189,440|15,160,834|15,460,167|



21 




**----- Start of picture text -----**<br>
THE MYTON HOSPICES<br>(A company limited by guarantee)<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
CONSOLIDATED BALANCE SHEET<br>AS AT 31 MARCH 2024<br>2024 2023<br>Note £ £ £ £<br>FIXED ASSETS<br>Intangible assets 14 61,515 75,427<br>Tangible assets 15 7,422,028 7,137,851<br>Investments 16 4,867,041 4,586,399<br>12,350,584 11,799,677<br>CURRENT ASSETS<br>Stocks 18 88,815 72,239<br>Debtors 19 1,310,983 546,232<br>Cash at bank and in hand 2,898,145 4,183,810<br>4,297,943 4,802,281<br>CREDITORS: amounts falling due<br>within one year 20 _(1,800,401) (1,441,124)<br>NET CURRENT ASSETS 2,497,542 3,361,157<br>NET ASSETS 14,848,126 15,160,834<br>CHARITY FUNDS<br>Restricted funds 22 173,505 189,440<br>Unrestricted funds 22 14,674,621 14,971,394<br>TOTAL FUNDS 14,848,126 15,160,834<br>**----- End of picture text -----**<br>


The financial statements were approved and authorised for issue by the Trustees on 21 August 2024 and signed on their behalf by: 

MrChairmanK W Demian Za 

The notes on pages 26 to 51 form part of these financial statements. 

22 




**----- Start of picture text -----**<br>
THE MYTON HOSPICES<br>(A company limited by guarantee)<br>**----- End of picture text -----**<br>



**----- Start of picture text -----**<br>
CHARITY BALANCE SHEET<br>AS AT 31 MARCH 2024<br>2024 2023<br>Note £ £ £ £<br>FIXED ASSETS<br>Intangible assets 14 61,515 75,427<br>Tangible assets 15 7,422,028 7,137,851<br>Investments 16 4,912,395 4,631,753<br>12,395,938 11,845,031<br>CURRENT ASSETS<br>Stocks 18 37,812 31,655<br>Debtors 19 1,146,141 496,987<br>Cash at bank and in hand 2,668,283 3,847,698<br>3,852,236 4,376,340<br>CREDITORS: amounts falling due<br>within one year 20 _ (1,447,960) (1,116,173)<br>NET CURRENT ASSETS 2,404,276 3,260,167<br>NET ASSETS 14,800,214 15,105,198<br>CHARITY FUNDS<br>Restricted funds 22 173,505 189,440<br>Unrestricted funds 22 14,626,709 14,915,758<br>TOTAL FUNDS 14,800,214 15,105,198<br>**----- End of picture text -----**<br>


The financial statements were approved and authorised for issue by the Trustees on 21 August OE by: 

Mr K W Demian 

Chairman 

The net outgoing resources for the financial year dealt with in the financial statements of the parent Charity were £304,984 (2023: net outgoing resources £298,600). 

The notes on pages 26 to 51 form part of these financial statements. 

23 



## THE MYTON HOSPICES (A company limited by guarantee) 

## CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH 2024 


**----- Start of picture text -----**<br>
||||||||||
|---|---|---|---|---|---|---|---|---|
|2024|2023|
|Note|£|£|
|Cash|flows|from|operating|activities|
|Net cash|(outflow)/inflow from|operating|activities|24|(932,006)|337,410|
|Cash|flows|from|investing|activities|
|Dividends and|interest from investments|214,308|130,832|
|Proceeds|from|disposal|of|tangible|fixed|assets|-|373|
|Purchase|of fixed|assets|(663,762)|{216,002)|
|Proceeds|from|sale|of|investments|636,355|552,565|
|Purchase|of investments|(540,560)|{660,472)|
|Net cash|used|in investing|activities|(353,659)|(192,704)|
|Change|in|cash|and|cash|equivalents|in the year|(1,285,665)|144,706|
|Cash and|cash|equivalents|brought|forward|4,183,810|4,039, 104|
|Cash|and|cash|equivalents|carried forward|25|2,898,145|4,183,810|

**----- End of picture text -----**<br>


24 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 1. CHARITY INFORMATION 

The Myton Hospices (the Charity) is a Company Limited by Guarantee (registered number 1628455), registered in England and Wales. Its charity registration number is 516287. The registered office and principal place of business is Myton Lane, Warwick, CV34 6PX. 

Its principal activities are specialist palliative and end of life care for the people of Coventry and Warwickshire, and provision of education in palliative and end of life care to healthcare professionals in Coventry and Warwickshire. 

2. ACCOUNTING POLICIES 

## 2.1 Basis of preparation of financial statements 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. 

The Myton Hospices meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy. 

The Statement of financial activities (SOFA) and Balance Sheet consolidate the financial statements of the Charity and its subsidiary undertaking. The results of the subsidiary are consolidated on a line by line basis. 

No separate SOFA has been presented for the Charity alone as permitted by section 408 of the Companies Act 2006. 

Trustees have a reasonable expectation that The Myton Hospices has adequate resources to continue in operational existence for the foreseeable future. There are no material uncertainties about the charity's ability to continue and therefore the Trustees adopt the going concern basis of accounting in preparing the financial statements. : 

## 2.2 Company status 

The company is a company limited by guarantee, incorporated in the United Kingdom. The members of the company are the Trustees named on page 1. In the event of the company being wound up, the liability in respect of the guarantee is limited to £1 per member of the company. 

## 2. ACCOUNTING POLICIES (continued) 

## 2.3 Basis of consolidation 

The financial statements consolidate the accounts of The Myton Hospices and all of its subsidiary undertakings (‘subsidiaries’). 

The Charity has taken advantage of the exemption contained within section 408 of the Companies Act 2006 not to present its own income and expenditure account. 

25 



THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 2.4 Fund accounting 

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes. 

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements. 

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements. 

Investment income, gains and losses are allocated to the appropriate fund. 

2. ACCOUNTING POLICIES (continued) 

2.5 Income 

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably. 

For legacies, entitlement is taken as the earlier of the date on which either: the Charity is aware that probate has been granted, the estate has been finalised and notification has been made by the executor(s) to the Trust that a distribution will be made, or when a distribution is received from the estate. Receipt of a legacy, in whole or in part, is only considered probable when the amount can be measured reliably and the Charity has been notified of the executor's intention to makea distribution. Where legacies have been notified to the Charity, or the Charity is aware of the granting of probate, and the criteria for income recognition have not been met, then the legacy is treated as a contingent asset and disclosed if material. 

Income from government and other grants is recognised when the charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received and the amount can be measured reliably and is not deferred. 

Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation. 

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable. 

Donated services or facilities are recognised when the Charity has control over the item, any conditions associated with the donated item have been met, the receipt of economic benefit from the use of the Charity of the item is probable and the economic benefit can be measured reliably. 

Clothing and other items donated for resale through the charity's shops are included as incoming resources within other trading activities when they are sold. They are not included at valuation prior to being sold as it has been deemed impractical to measure the fair value of the goods and the cost of valuation would outweigh the benefit to the users of the accounts. 

26 



THE MYTON HOSPICES (A company limited by guarantee) 

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

The hospice receives the help and support of up to 1,200 volunteers, who help in every aspect of the organisation, and are both patient facing and within support services, as well as fundamental in the delivery of fundraising activities. Due to an absence of a reliable measurement basis, the contribution of these general volunteers has not been accounted for. 

Lottery income is recognised when receivable. 

Investment income is included when receivable. 

2.6 Expenditure 

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds. 

Charitable activities and Governance costs are costs incurred on the company's operations, including support costs and costs relating to the governance of the company apportioned to charitable activities. 

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. 

All expenditure is accounted for on an accruals basis. All expenses including support costs and governance costs are allocated to the applicable expenditure headings. 

Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of charitable activities. Specifically, it comprises those costs of trading for fundraising purposes including the charity's shops and lottery. 

Governance costs include those costs associated with meeting the constitutional and statutory requirements of the charity and include the audit fees. 

Redundancy payments are accounted for as staff costs and are recognised on communication of intention to pay. 

All costs are allocated between the expenditure categories of the Statement of Financial Activities on a basis designed to reflect the use of the resources. Costs relating to a particular activity are allocated directly. Remaining support costs are all charged to charitable expenditure since those relating to fundraising are considered immaterial. 

## 2.7 Going concern 

We have set out in the Trustees’ Report a review of the financial performance and the charity's reserves position. We have a reasonable expectation that we have adequate resources to continue in operational existence for the foreseeable future. We believe that there are no material uncertainties that call into doubt the charity's ability to continue. The financial statements have therefore been prepared on the basis that the charity is a going concern. 

27 



THE MYTON HOSPICES 

(A company limited by guarantee) 

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 2. ACCOUNTING POLICIES (continued) 

## 2.8 Intangible fixed assets and amortisation 

Software assets are stated at cost less amortisation. Amortisation is provided at rates calculated to write off the cost of intangible assets, over their expected useful lives which is estimated at between 5-10 years. 

Amortisation is charged to expenditure on charitable activities in the Statement of financial activities. 

## 2.9 Tangible fixed assets and depreciation 

All assets costing more than £2,000 are capitalised. 

A review for impairment of a fixed asset is carried out where events or changes in circumstances indicate that the carrying amount of the fixed asset may otherwise be overstated. Such events or changes in circumstances include changes in useful life arising from changes in business activities or environment, significant decline in an asset's market value during the period, or evidence of obsolescence or physical damage to the' asset. Impairment losses arising are charged to the Statement of financial activities. 

Where the impairment is subsequently reduced or removed the carrying value is reinstated to the lower of the revised value or the amount at which it would have been carried had no impairment occurred, the amount of impairment released being credited to the Statement of financial activities. 

Tangible fixed assets are carried at cost, net of depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated residual value, over their expected useful lives on the following bases: 


**----- Start of picture text -----**<br>
|||||||||||
|---|---|---|---|---|---|---|---|---|---|
|Freehold|property|- 20|- 40 years|
|Freehold|land|-|Not|depreciated|
|L/Term|leasehold|property|- Over|the|period|of|lease|or 50|years|
|Property|improvements|-3-10|years|
|Furniture,|equipment|and|vehicles|-3-|10|years|
|Computer|and|office|equipment|-3-|10 years|
|Shop and|office|fittings|- Over period|of|lease|
|Solar panels|-|20 years|

**----- End of picture text -----**<br>


2.10 investments 

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless fair value cannot be measured reliably in which case it is measured at cost less impairment. investment gains and losses, whether realised or unrealised, are combined and shown in the heading 'Gains/(losses) on investments’ in the Statement of financial activities. 

(i) Investments in subsidiaries are valued at cost less provision for impairment. 

28 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 2. ACCOUNTING POLICIES (continued) 

## 2.11 Interest receivable 

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the Bank. 

## 2.12 Operating leases 

Rentals under operating leases are charged to the Statement of financial activities on a straight line basis over the lease term. Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight line basis over the period until the date the rent is expected to be adjusted to the prevailing market rate. 

## 2.13 Stocks and work in progress 

Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. 

## 2.14 Debtors 

Trade and other debtors are recognised at the settlement amount affer any trade discount offered. 

2.15 Cash at Bank and in hand 

Cash at bank and in hand includes cash and short term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account. 

## 2.16 Creditors and provisions 

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably. Liabilities are recognised at the amount that the company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide. Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised within interest payable and similar charges. 

## 2.17 ‘Financial instruments 

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method. 

29 



THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 2. ACCOUNTING POLICIES (continued) 

## 2.18 Pensions 

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year. 

The Charity operates a defined benefits pension scheme. The scheme is a multi-employer scheme where it is not possible, in the normal course of events, to identify on a consistent and reasonable basis, the share of underlying assets and liabilities belonging to individual participating employers. Therefore the Charity accounts for this scheme as if it was a defined contribution scheme. The amount charged fo the Statement of financial activities represents contributions payable to the scheme in respect of the accounting period. 

## 2.19 Significant judgements and estimates 

Preparation of the financial statements may require management to make significant judgements and estimates. 

## Significant judgements 

Donated goods for resale are not included at valuation prior to being sold as it has been deemed impractical to measure the fair value of the goods and the cost of valuation would outweigh the benefit to the users of the accounts. 

## Significant estimates 

There are no significant estimates having a material effect on the financial statements. 

## 2.20 

## Agency arrangements 

The Charity acts as an agent in administering funds for "GP PMS Education" on behalf of the NHS. Income and expenditure in relation to the project is excluded from the statement of financial activities as the Charity does not have control over the charitable application of the funds. The funds received and paid and any balances held are disclosed in note 21. 

|3.<br>INCOME FROM DONATIONS AND|LEGACIES||||
|---|---|---|---|---|
||Unrestricted<br>funds|Restricted<br>funds|Total<br>funds|Total<br>funds|
||2024|2024|2024|2023|
||£|£|£|£|
|Donations<br>Legacies|3,046,782<br>1,437,604|521,494<br>-|3,568,276<br>1,437,604|3,171,455<br>= 1,269,289|
|Grants:|||||
|Hospice UK Covid-19|-|-|-|83,159|
|Total donations, legaciesand grants|4,484,386|§21,494|5,005,880|4,523,903|
|Total2023|4,158,288|365,615|_4,523,903||



30 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 4. INCOME FROM CHARITABLE ACTIVITIES 

||Unrestricted|Total|Total|
|---|---|---|---|
||funds|funds|funds|
||2024|2024|2023|
||£|£|£|
|NHS grants and contracts forpatient care|2,695,681|2,695,681|2,649,905|
|Education and trainingincome|25,390|25,390|34,085|
||2,721,071|2,721,071|2,683,990|
|Total2023|2,683,990|2,683,990||
|5.<br>OTHER TRADING INCOME - FUNDRAISING INCOME||||
||Unrestricted|Total|Total|
||funds|funds|funds|
||2024|2024|2023|
||£|£|£|
|Retail income|2,755,149|2,755,149|2,617,123|
|Lotteryincome|2,057,931|2,057,931|2,261,103|
|Otherincome|§1,355|§1,355|43,097|
|Total2023|4,921,323|4,921,323||
|é.<br>INVESTMENTINCOME||||
||Unrestricted|Total|Total|
||funds|funds|funds|
||2024|2024|2023|
||£|£|£|
|Interest|67,429|67,429|15,544|
|Dividend income|146,879|146,879|115,288|
||214,308|214,308|130,832|
|Total2023|130,832|130,832||



## 5. OTHER TRADING INCOME - FUNDRAISING INCOME 

## é. INVESTMENT INCOME 

31 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 7. ANALYSIS OF EXPENDITURE BY EXPENDITURE TYPE 

||Staff<br>costs|Depreciation|Other<br>costs|Total<br>2024|Total<br>2023|
|---|---|---|---|---|---|
||£|£|£|£|£|
|Expenditure on raising voluntary||||||
|and trading income|2,116,267|-|1,683,122|3,799,389|3,495,496|
|Expenditure on investment|-|-|24,894|24,894|21,061|
|management||||||
|Cost of raising funds|2,116,267|-|1,708,016|3,824,283|3,516,557|
|Expenditure relating to delivery||||||
|ofNHSgrantsand contracts for|7,648,546|386,216|1,715,402|9,750,164|8,767,993|
|patientcare||||||
||9,764,813|386,216|3,423,418|13,574,447|12,284,550|
|Total2023|8,606,549|345,982|3,332,019|12,284,550||



## 8. EXPENDITURE ON RAISING VOLUNTARY AND TRADING INCOME 

||Unrestricted|Total|Total|
|---|---|---|---|
||funds|funds|funds|
||2024|2024|2023|
||£|£|£|
|Retail and lottery costs|1,452,688|1,452,688|1,488,464|
|Fundraising costs|230,434|230,434|163,153|
|Staff costs|2,116,267|2,116,267|1,843,879|
||3,799,389|_3,799,389|_3,495,496|
|Total2023|3,495,496|3,495,496||



32 



## THE MYTON HOSPICES 

## (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 9. ANALYSIS OF EXPENDITURE BY ACTIVITIES 

||Activities|Support|||
|---|---|---|---|---|
||undertaken<br>directly<br>£|costs<br>£|Total<br>2024<br>£|Total<br>2023<br>F|
|NHS grantsand contracts forpatient care|8,490,045|1,260,119|9,750,164|8,767,993|
|Total2023|7,561,931|1,206,062|_8,767,993||



## 10, DIRECT COSTS - NHS GRANTS AND CONTRACTS 

||2024|2023|
|---|---|---|
||£|£|
|Drugs|280,820|234,917|
|Medicinal supplies|133,078|117,986|
|Cleaningand laundry|57,504|45,138|
|Catering|112,683|79,960|
|Smallequipment|27,698|33,098|
|Training|22,563|34,486|
|Governance|10,500|10,000|
|Contracted medical staff|196,653|243,676|
|Wages and salaries|6,494,840|5,762,173|
|National insurance|$623,215|559,011|
|Pension cost|530,491|441,486|
||8,490,045|7,561,931|
|Total2023|7,561,931||



33 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 11. SUPPORT COSTS - NHS GRANTS AND CONTRACTS 

||2024|2023|
|---|---|---|
||£|£|
|Premises costs|200,570|178,710|
|Travelling and subsistence|23,039|29,392|
|Office costs|176,223|152,624|
|Repairsand renewals|164,309|211,373|
|Legaland professional|(2,266)|28,423|
|Staff recruitment|6,276|6,392|
|Other costs|298,471|251,782|
|Loss on disposal of tangible fixed assets|7,281|1,384|
|Amortisation|17,514|14,546|
|Depreciation|368,702|331,436|
||1,260,119|1,206,062|
|Total2023|1,206,062||
|12.<br>NET INCOME/(EXPENDITURE)|||
|This is stated after charging:|||
||2024|2023|
||£|£|
|Depreciation of tangible fixed assets|||
|-owned by the charitable group|368,702|331,436|
|Auditor's remuneration - audit|14,800|14,025|
|Auditor's remuneration - tax|1,250|1,250|
|Operatingleaserentals|419,331|407,845|



During the year, no Trustees received any remuneration (2023 - ENil) During the year, no Trustees received any benefits in kind (2023 - £Nil) During the year, no Trustees received any reimbursement of expenses (2023 - £Nil) 

34 



THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 13. STAFF COSTS 

Staff costs were as follows: 


**----- Start of picture text -----**<br>
||||||
|---|---|---|---|---|
|2024|2023|
|£|£|
|Wages and|salaries|8,378,328|7,396,335|
|Social|security|costs|768,209|691,138|
|Other|pension|costs|618,276|519,076|
|9,764,813|8,606,549|

**----- End of picture text -----**<br>


Non-statutory/non-contractual termination payments totalling £Nil (2023: £14,967) were made to zero (2023: three) employees. 

The average number of persons employed by the company during the year was as follows: 


**----- Start of picture text -----**<br>
|||||||||
|---|---|---|---|---|---|---|---|
|2024|2023|
|No.|No.|
|306|297|
|The|number|of|higher|paid|employees was:|
|In|the|band|£60,001|to|£70,000|]|2|
|In|the|band|£70,001|to|£80,000|4|3|
|In|the|band|£80,001|to £90,000|||1|
|In|the|band|£90,001|to|£100,000|2|]|
|In|the|band|100,001|to £110,000|1|]|

**----- End of picture text -----**<br>


Of the higher paid employees 4 members of the medical team are paid on the NHS pay scale (2022-23 : 3) 

35 



THE MYTON HOSPICES (A company limited by guarantee) 

NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 14, INTANGIBLE FIXED ASSETS 

||||||Software|
|---|---|---|---|---|---|
||||||£|
|GroupandCompany||||||
|Cost||||||
|At 1 April 2023|||||212,410|
|Additions<br>Disposals<br>At 31 March 2024|||||3,716<br>(2,910)<br>213,216|
|Amortisation||||||
|At 1 April 2023|||||136,983|
|Charge fortheyear|||||17,514|
|At 31 March 2024|||||(2,796)<br>151,701|
|CarryingAmount||||||
|At 31 March 2024|||||61,515|
|At31 March 2023|||||75,427|
|15.<br>TANGIBLE FIXED ASSETS||||||
|||Long|Furniture,|©Computer||
||Freehold|Leasehold|equipment|& office||
||Property|Property|&vehicles|equipment|Total|
||£|£|£|£|£|
|Group||||||
|Cost||||||
|At 1 April 2023|3,815,457|7,775,662|2,459,390|387,318|14,437,827|
|Additions|101,425|112,795|332,713|113,113|660,046|
|Disposals|(23,010)|-|(194,761)|(196,514)|(414,285)|
|At31 March 2024|3,893,872|7,888,457|2,597,342|303,917|14,683,588|
|Depreciation||||||
|At 1 April2023<br>Charge fortheyear<br>Disposals|1,988,961<br>63,595<br>(18,605)|3,081,927<br>85,270<br>-|1,901,601<br>184,978<br>(192,156)|327,487<br>34,859<br>(196,357)|7,299,976<br>368,702<br>(407,118)|
|At 31 March 2024|2,033,951|3,167,197|1,894,423|165,989|7,261,560|
|Netbook value||||||
|At31 March 2024|1,859,921|4,721,260|702,919|137,928|7,422,028|
|At31March2023|1,826,496|4,693,735|557,789|59,831|7,137,851|



## 15. TANGIBLE FIXED ASSETS 

Included in freehold property is land of £1,114,199 which is not depreciated. 

36 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 15. TANGIBLE FIXED ASSETS CONTINUED 

||||Long|Long|Furniture,|©Computer||
|---|---|---|---|---|---|---|---|
|||Freehold|Leasehold||equipment|& office||
|||Property|Property||&vehicles|equipment|Total|
|||£||£|£|£|£|
|Charity||||||||
|Cost||||||||
|At 1 April2023|3,815,457||7,770,662||2,459,390|387,318|14,432,827|
|Additions||101,425|112,795||332,713|113,113|660,046|
|Disposals||(23,010)||-|(194,761)|(196,514)|(414,285)|
|At31 March2024|3,893,872||7,883,457||2,597,342|303,917|14,678,588|
|Depreciation||||||||
|At 1 April2023|1,988,961||3,076,927||1,901,601|327,487|7,294,976|
|Charge fortheyear||63,595|85,270||184,978|34,859|368,702|
|Disposals||(18,605)||-|(192,156)|(196,357)|(407,118)|
|At 31 March 2024|2,033,951||3,162,197||1,894,423|165,989|7,256,560|
|Netbook value||||||||
|At31 March 2024|1,859,921||4,721,260||702,919|137,928|7,422,028|
|At31 March 2023|1,826,496||4,693,735||557,789|59,831|7,137,851|
|Included in freehold property is||land of£1,114,199||which|is notdepreciated.|||
|16.<br>FIXED ASSET INVESTMENTS||||||||
||||||Listed|||
|Group|||||securities|Land|Total|
||||||£|£|£|
|Market Value||||||||
|At 1 April 2023|||||4,518,899|67,500|4,586,399|
|Additions<br>Disposals<br>Revaluations|||||540,560<br>(568,855)<br>376,437|-<br>(67,500)<br>:|540,560<br>(636,355)<br>376,437|
|At 31 March 2024|||||4,867,041|:|4,867,041|
|Group investments atmarketvaluecomprise:||||||2024|2023|
|||||||£|£|
|Listed investments||||||4,867,041|4,518,899|
|Other fixed assetinvestments||||||-|67,500|
|Total market value||||||4,867,041|4,586,399|
|All of the fixed asset investments are held in the UK||||||||
|||||||31 March|31 March|
|Group material investments||||||2024|2023|
|Vanguard FundsPLC||||||£<br>398,005|F<br>314,588|



## 16. FIXED ASSET INVESTMENTS 

37 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 16. FIXED ASSET INVESTMENTS (continued) 

||Listed||||
|---|---|---|---|---|
||securities|Land|Subsidiaries|Total|
||£|£|£|£|
|Charity|||||
|Market Value|||||
|At 1 April2023|4,518,899|67,500|45,354|4,631,753|
|Additions|540,560|-|-|540,560|
|Disposals<br>Revaluations|(568,855)<br>376,437|(67,500)<br>:|.<br>-|(636,355)<br>376,437|
|At 31 March 2024|4,867,041|:|45,354|4,912,395|
|Charity investments at marketvalue comprise:|||||
||||2024|2023|
||||£|F|
|Listed investments|||4,867,041|4,518,899|
|Other fixed asset investment|||-|67,500|
|Group|||45,354|45,354|
|Total|||4,912,395|4,631,753|



All the fixed asset investments are held in the UK 

## 17, PRINCIPAL SUBSIDIARIES 

100% of the issued share capital of Myton Hospice (Promotions) Limited and Myton Hamlet Hospice Development Limited is held by the Charity. 

Myton Hospice (Promotions) Limited operates charity shops and a lottery to raise funds for the Charity. The company pays its taxable profits to the Charity by way of Gift Aid. The company is registered in England and its company number is 2663993. In addition to its trading results disclosed below, the company processed sales of £782,554 (2023: £824,006) relating to donated goods sold under the retail Gift Aid scheme. These figures are included as retail income on the Statement of Financial Activities. 

Myton Hamlet Hospice Development Limited develops and builds properties which are then sold to the Charity. The company is registered in England and its company number is 3059410. 

38 



## THE MYTON HOSPICES 

(A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 17. PRINCIPAL SUBSIDIARIES (continued) 

||||Myton|Myton Hamlet|
|---|---|---|---|---|
||||Hospice|Hospice|
||||(Promotions)|Development|
||||Limited|Limited|
||||£|£|
|Grossincome|||4,058,324|-|
|Expenditure|||(3,005,568)|(757)|
|Gift aid to the Charity|||(1,059,723)|-|
|Loss in the period|||(6,967)|(757)|
||||£|£|
|Net assets/(liabilities) attheyearend|||96,663|(3,396)|
|18.<br>STOCKS|||||
|||Group||Charity|
||2024|2023|2024|2023|
||£|£|£|£|
|Consumables|31,174|31,093|31,174|31,093|
|Goods for resale|57,641|41,146|6,638|562|
||88,815|72,239|37,812|31,655|
|19.<br>DEBTORS|||||
|||Group||Charity|
||2024|2023|2024|2023|
||£|Fa|£|£|
|Trade debtors|790,786|10,640|790,786|10,640|
|Amounts owed by group undertakings|.|-|8,783|115,832|
|Other debtors|150,779|115,776|113,774|84,631|
|Prepaymentsand accrued income|369,418|558,761|232,798|423,263|
||1,310,983|546,232|1,146,141|496,987|



39 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 20. CREDITORS: amounts falling due within one year 

|||Group||Charity|
|---|---|---|---|---|
||2024|2023|2024|2023|
||£|£|£|£|
|Trade creditors|347,221|393,914|259,457|336,346|
|Amountsowed togroup undertakings|-|-|-|-|
|Other taxation and social security|175,505|170,961|175,505|170,961|
|Other creditors|133,332|118,634|133,332|118,635|
|Accruals and deferred income|1,144,343|757,615|879,666|490,231|
||1,800,401|1,441,124|1,447,960|1,116,173|
|||Group||Charity|
||2024|2023|2024|2023|
|Deferred income|£|£|£|£|
|Deferred income at 1 April 2021|284,289|831,880|84,079|645,263|
|Resources deferred during theyear|928,434|24,747|736,185|-|
|Amounts released from previousyears|(283,739)|(180,490)|(83,529)|(161,870)|
|Deferredincomeat31March2022|928,984|284,289|736,735|84,079|



Deferred income comprises lottery income received in advance by Myton Hospice (Promotions) Limited of £192,349 (2023: £210,210), Challenge Event income of £65,378 (2023: £83,529), Funding for Quality end of Life care for all training courses of £550 (2023: £550) and NHS grants and contracts for patient care income of £670,707 (2023: £Nil). 

## 21. AGENCY ARRANGEMENTS 

The Charity acts as an agent in administering funds for "GP PMS Education" on behalf of the NHS. In the accounting period ending 31 March 2024 the Charity received £Nil (2023: £Nil) and disbursed £Nil (2023: £Nil) from the fund. An amount of £11,057 (2023: £11,269) is included in other creditors relating to undistributed funds. 

40 



THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 22. STATEMENT OF FUNDS 


**----- Start of picture text -----**<br>
|||||||||||
|---|---|---|---|---|---|---|---|---|---|
|Balance at|Income|Expenditure|Transfers|Gains/|Balance at|
|1|April|in/out|(Losses)|31|March|
|2023|2024|
|£|£|£|£|£|£|
|Designated funds|
|Fixed|asset|fund|7,213,278|-|(393,497)|663,762|-|7,483,543|
|nvesitment|fund|4,586,399|196,646|(24,894)|(267,547)|376,437|4,867,041|
|Service|expansion|fund|116,679|-|(45)|-|:|116,634|
|Warwick|hospice|500,000|-|-|-|-|500,000|
|improvements|fund|
|Project|funds:|
|Expanding|services|465,963|-|(13,913)|-|-|452,050|
|beyond|Warwick|walls|
|Digital|strategy and|152,585|-|(56,215)|-|:|96,370|
|transformation|project|
|Innovation fund|1,000,060|:|(141,174)|-|-|858,826|
|14,034,904|196,646|(629,738)|396,215|376,437|14,374,464|
|General funds|
|General|Funds|-|all|936,490|12,167,162|(12,597,658)|(205,837)|-|300,157|
|funds|
|Total|Unrestricted|funds|14,971,394|12,363,808|(13,227,396)|190,378|376,437|14,674,621|
|Restricted funds|
|Other|donations|184,175|521,494|(347,051)|(190,378)|-|168,240|
|Vehicle fund|5,265|:|-|-|-|5,265|
|189,440|521,494|(347,051)|(190,378)|:|173,505|
|Total|of funds|15,160,834|12,885,302|(13,574,447)|-|376,437|14,848,126|

**----- End of picture text -----**<br>


41 



THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 22. STATEMENT OF FUNDS (continued) 

## STATEMENT OF FUNDS — PRIOR YEAR 


**----- Start of picture text -----**<br>
|||||||||||
|---|---|---|---|---|---|---|---|---|---|
|Balanceat|income|Expenditure|Transfers|Gains/|Balance|at|
|1|April|in/out|(Losses)|31|March|
|2022|2023|
|£|£|£|£|£|£|
|Designated|funds|
|Fixed|asset|fund|7,345,016|-|{345,982}|214,244|-|7,213,278|
|Investment|fund|4,773,085|115,288|(21,061)|13,680|(294,593)|4,586,399|
|Service|expansion|fund|116,730|-|(51)|-|-|116,679|
|Warwick|hospice|500,000|-|-|-|-|500,000|
|improvements|fund|
|Project|funds:|
|Warwick|IPU beds|300,000|-|(300,000)|-|-|-|
|Estates|and equipment|67,779|-|-|{67,779}|-|-|
|capital|expenditure|
|Expanding|services|488,547|-|(22,584)|-|-|465,963|
|beyond Warwick|walls|
|Digital strategy and|181,945|-|(29,360)|-|-|152,585|
|transformation|project|
|Innovation|fund|1,000,000|-|-|-|-|1,000,000|
|14,773,102|115,288|(719,038)|160,145|(294,593)|14,034,904|
|General funds|
|General|Funds|-|all|539,240|11,798,907|(11,350,132)|(51,525)|-|936,490|
|funds|
|Total|Unrestricted|funds|=|15,312,342|11,914,195|(12,069,170)|108,620|(294,593)|14,971,394|
|Restricted|funds|
|Other donations|126,160|282,456|(132,221)|(92,220)|-|184,175|
|Vehicle|fund|21,665|-|-|(16,400)|-|5,265|
|Hospice|UK Covid-19|-|83,159|(83,159)|-|-|-|
|fund|
|147,825|365,615|(215,380)|(108,620)|-|189,440|
|Total|of funds|15,460,167|12,279,810|(12,284,550)|-|(294,593)|15,160,834|

**----- End of picture text -----**<br>


42 



THE MYTON HOSPICES 

; 

(A company limited by guarantee) 

NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 22. STATEMENT OF FUNDS (continued) 

The majority of transfers between funds represent the designation of project funds and the amount spent on fixed assets, which, now that the income has been spent in accordance with the donor’s wishes, have been transferred to the designated fixed asset fund. 

## Designated funds 

## Fixed assets fund 

A large part of the unrestricted funds of the Charity are represented by tangible fixed assets (mainly land and buildings) required for the Charity to continue operating. As these assets are considered not normally realisable, the Trustees have designated funds equal to their book value. 

## Investment fund 

in the year ended 31 March 2001, the Trustees set aside £2,000,000 in an investment fund with the aim of providing a regular source of income each year. Gains and losses on the investments held are credited or charged to the fund each year and the year end balance equals the market value of investments held. 

## Service expansion 

In the year ended 31 March 2014, the Trustees designated funds of £750,000 to seed fund a number of new services between 2015 and 2018. These funds include £220,000 matched funding received from NHS South Warwickshire CCG for the Good to Great project. 

## Warwick Hospice improvements fund 

In the year ended 31 March 2020, the Trustees designated funds of £75,000 to fund improvements to the Warwick Hospice. The Trustees designated an additional £425,000 in the year ended 31 March 2021. 

## Project funds 

In the year ended 31 March 2024 the Trustees designated funds for the following projects in order to ensure the Hospice’s sustainability and to extend the reach of the Hospice’s services to those who currently do not access them: 

1. Opening 4 beds in Warwick IPU. The IPU in Warwick was reduced to 12 beds due to reducing numbers of referrals throughout the pandemic. Work is ongoing to improve the relationship with referrers in Warwick. Once there is demand over and above 12 beds this funding would allow the recruitment of staff and re-opening of 4 beds. Past trends show that increasing patient numbers also correlates with increased voluntary income through donations. 

43 



THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

22. STATEMENT OF FUNDS (continued) 

   2. Capital expenditure on replacement equipment and to make improvements to the Hospices. These projects had previously been declined at budget setting due to financial constraints. Now we see that our favourable financial position gives us the opportunity to invest in our sites, improving their sustainability. 

   3. “Expanding our services beyond the Hospice walls”. This funding would allow the Hospice to “pump prime” initiatives, and prove the concept, with the intention that funding / commissioning organisations will agree to fund the future services once proven. Plans for our expansion into the community are ongoing and any application of these funds will be agreed by the usual process by being agreed by the board of trustees. 

   4. Digital Strategy and Transformation project. This project will review the data held within the organisation and what IT solutions could help with the administration and storage of this data. New systems to manage data will be proposed and the costs of the scoping work and new system implementation will come out of this fund. 

   5. Innovation fund. With strong patient and family care and support already emphatically being delivered despite the challenging economic landscape, the emphasis on future development requires a more innovative approach, in order to extend our reach and influence. With this in mind Trustees are seeking to maximise our strong reserves position, so have allocated a designated fund of £im, for the executive team to explore imaginative new ways to support the local community. 

## Restricted funds 

Various donations received for other specific purposes laid down by the donors are carried forward as restricted funds until spent. 

|SUMMARY OF FUNDS—CURRENT YEAR|SUMMARY OF FUNDS—CURRENT YEAR||||||
|---|---|---|---|---|---|---|
||Balance at|||||Balance at|
||1April|||Transfers|Gains/|31March|
||2023|hcome_|Expenditure|in/out|(Losses)|2024|
||£|£|£|£|£|£|
|Designatedfunds|14,034,904|196,646|(629,738)|396,215|376,437|14,374,464|
|Generalfunds|936,490|12,167,162|(12,597,658)|_(205,837)|:|300,157|
||14,971,394|12,363,808|(13,227,396)|190,378|376,437|14,674,621|
|Restrictedfunds|189,440|521,494|(347,051)|_(190,378)|:|173,505|
||15,160,834|12,885,302|_(13,574,447)|-|_376,437|14,848,126|



44 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 22. STATEMENT OF FUNDS (continued) 

## SUMMARY OF FUNDS — PREVIOUS YEAR 


**----- Start of picture text -----**<br>
|||||||||
|---|---|---|---|---|---|---|---|
|Balance|at|Balance|at|
|1|April|Transfers|Gains/|31|March|
|2022|hcome|Expenditure|n/out|(Losses)|2023|
|£|£|£|£|£|£|
|Designated funds|14,773,102|«115,288|(719,038)|160,145|(294,593)|14,034,904|
|General funds|539,240|11,798,907|__|{11,350,132}|(51,525)|-|936,490|
|15,312,342|11,914,195|(12,069,170)|108,620|(294,593)|14,971,394|
|Restricted funds|147,825|__365,615|(215,380)|(108,620)|-|189,440|
|15,460,167|12,279,810|(12,284,550)|= _ (294,593)|15,160,834|

**----- End of picture text -----**<br>


## 23. ANALYSIS OF NET ASSETS BETWEEN FUNDS 

## ANALYSIS OF NET ASSETS BETWEEN FUNDS - CURENT YEAR 


**----- Start of picture text -----**<br>
|||||||
|---|---|---|---|---|---|
|Unrestricted|Restricted|Total|
|funds|funds|funds|
|2024|2024|2024|
|£|£|£|
|Intangible|fixed|assets|61,515|-|61,515|
|Tangible|fixed|assets|7,422,028|-|7,422,028|
|Fixed|asset|investments|4,867,041|-|4,867,041|
|Current|assets|4,124,438|173,505|4,297,943|
|Creditors|due within one year|(1,800,401)|-|(1,800,401)|
|14,674,621|173,505|14,848,126|

**----- End of picture text -----**<br>


## ANALYSIS OF NET ASSETS BETWEEN FUNDS — PRIOR YEAR 


**----- Start of picture text -----**<br>
|||||||
|---|---|---|---|---|---|
|Unrestricted|Restricted|Total|
|funds|funds|funds|
|2023|2023|2023|
|£|£|£|
|Intangible fixed|assets|75,427|.|75,427|
|Tangible|fixed|assets|7,137,851|-|7,137,851|
|Fixed asset|investments|4,586,399|-|4,586,399|
|Current|assets|4,612,84]|189,440|4,802,281|
|Creditors|due within one year|(1,441,124)|-|(1,441,124)|
|14,971,394|189,440|15,160,834|

**----- End of picture text -----**<br>


45 



THE MYTON HOSPICES (A company limited by guarantee) 

NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 24. RECONCILIATION OF NET MOVEMENT IN FUNDS TO NET CASH FLOW FROM OPERATING ACTIVITIES 


**----- Start of picture text -----**<br>
||||||||||
|---|---|---|---|---|---|---|---|---|
|Group|
|2024|2023|
|£|£|
|Net income/(expenditure)|for|the|year|(as|per Statement|of|(312,708)|(299,333)|
|Financial|Activities)|
|Adjustment|for:|
|Depreciation|and|amortisation|charges|386,216|345,982|
|(Gains)/losses|on|investments|(376,437)|294,593|
|Dividends and|interest from investments|(214,308)|(130,832)|
|Increase|in|stocks|(16,576)|(9,117)|
|(Increase)/decrease|in|debtors|(764,751)|810,861|
|Increase/{decrease)|in|creditors|359,277|(676, 128)|
|Loss|on|disposal|of|tangible|fixed|7,281|1,384|
|assets|
|Net cash|(outflow)/inflow|from|operating|activities|(932,006)|337,410|

**----- End of picture text -----**<br>


25. ANALYSIS OF CASH AND CASH EQUIVALENTS 


**----- Start of picture text -----**<br>
||||||||
|---|---|---|---|---|---|---|
|Group|
|2024|2023|
|£|£|
|Cash|at|bank and|in|hand|2,898,145|4,183,810|
|Total|2,898,145|4,183,810|
|26.|PENSION|COMMITMENTS|

**----- End of picture text -----**<br>


Staff may opt to join a defined contribution pension scheme, the assets of which are held separately from those of the charity in independently administered funds. The employer's contribution to this scheme is between 2% and 10% (2023: 2% and 10%) of pensionable pay. 

Staff previously employed by the National Health Service and who were members of the NHS Superannuation Scheme continue to be members of that scheme. The NHS scheme is a defined benefit pension scheme. However, the scheme is a multiple employer scheme and the group is unable to identify its share of fhe underlying assets and liabilities. The scheme is therefore accounted for as a defined contribution scheme. Contributions are charged to the SOFA so as to spread the cost of pensions over employees’ working lives with the charity. 

Details of the benefits payable under these provisions can be found on the NHS Pensions website at www.nhsbsa.nhs.uk/nhs-pensions 

The employer's contribution to the scheme is 14.38% (2023: 14.38%) of pensionable pay. 

The pension cost charges, representing employer's contributions to both schemes, amounted to £618,276 (2023: £519,076). Contributions totalling £89,438 (2023: £81,476) were payable at the year end and are included in other creditors. 

46 



## THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 26. PENSION COMMITMENTS (continued) 

Future contributions are expected to be at a similar level. 

No trustee qualified for benefits under either of these schemes. 

27. OPERATING LEASE COMMITMENTS 

At 31 March 2024 the total of the groups future minimum lease payments under non-cancellable operating leases was: 

|Group|2024|2023|
|---|---|---|
|Amounts payable|£|£|
|Within 1 year|268,899|325,123|
|Between 1 and 5years|835,733|604,041|
|After more than 5years|69,173|83,918|
|Total|1,173,805|1,013,082|
|At31 March 2024 the Charity had annual commitments undernon-cancellable operating leases|||
|as follows:|||
|Charity|2024|2023|
|Amounts payable|£|£|
|Within 1 year|229,867|260,009|
|Between 1 and 5years|798,344|527,443|
|After more than 5years|69,173|83,918|
|Total|1,097,384|871,370|



At 31 March 2024 the Charity had annual commitments under non-cancellable operating leases as follows: 

## 28. RELATED PARTY TRANSACTIONS 

There have been no other related party transactions that require disclosure other than transactions with the subsidiary company Myton Hospice (Promotions) Limited as set out below: 

||2024|2023|
|---|---|---|
||£|£|
|Management fees|109,090|171,08)|
|Payroll costs recharged|1,475,899|1,294,595|
|income from donated goods underthe retail Gift Aid|949,901|1,008,441|
|scheme|||
|Lottery excess pence donation income|209,464|13,226|
|GiftaidtransferredtotheCharity|1,059,723|1,234,646|



Management fees were calculated as a proportion of the senior leadership teams salaries, and overheads of the management company. 

Payroll costs relate to the salaries of the employees who are paid by Myton Hospice, yet work within one of Myton Hospice Promotions Limited services. 

Income from donated goods under the retail Gift Aid scheme are sales which were processed by Myton Hospice (Promotions) Limited on behalf of the Charity and are included under retail income. 

47 



## THE MYTON HOSPICES (A company limited by guarantee) NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 28. RELATED PARTY TRANSACTIONS (continued) 

Gift aid relates to gift aid recovered by Myton Hospice (Promotions) Limited on behalf of the Charity. 

The balance outstanding at the year end owed from Myton Hospice (Promotions) Limited was £5,468 (2023: £113,525). The balance outstanding at the year end owed to Myton Hospice (Promotions) Limited was E£Nil (2023: £Nil). 

The balance outstanding at the year end owed from Myton Hamlet Hospice Development Limited was £3,315 (2023: £2,307). 

The key management personnel of the charity comprise the CEO and Directors of Income Generation and Supporter Development, Finance and Commercial Development, Nursing Care and Service Development, Corporate Resources, People Services and the Medical Director. The total employee benefits of the key management personnel of the charity were £597,957 (2023: £594,267). 

## 29. FINANCIAL INSTRUMENTS 

|29.<br>FINANCIAL INSTRUMENTS|||||
|---|---|---|---|---|
|||Group||Charity|
||2024|2023|2024|2023|
|Financial assets|£|£|£|£|
|Financial assets measured at fair value|||||
|through incomeand expenditure|4,867,041|4,518,899|4,912,395|4,564,253|
|Financial assets that are debt|||||
|instruments measured at amortised|||||
|cost|3,791,268|4,337,431|3,557,854|3,993,649|
|Financial liabilities|||||
|Financial liabilities|||||
|measured at amortised|||||
|cost|695,912|985,874|535,820|861,134|



Financial assets measured at fair value through income and expenditure comprises investments in UK listed securities. Financial assets measured at amortised cost comprise cash at bank, trade debtors and accrued income. Financial liabilities measured at amortised cost comprise trade creditors, accruals and other creditors. 

The group’s income, expense, gains and losses in respect of financial instruments are summarised below: 

|||||Group||Charity|
|---|---|---|---|---|---|---|
||||2024|2023|2024|2023|
||||£|£|£|£|
|Total|investment income|for financial|||||
|assets measured at fair value through|||||||
|income andexpenditure|||146,879|115,288|146,879|115,288|
|Net|gains/(losses}<br>on<br>financial<br>assets||||||
|measured at fair value through income|||||||
|and|expenditure||376,437|(294,593)|376,437|(294,593)|
|Total|investment income|for financial|||||
|assetsmeasuredatamortisedcost|||67,429|15,544|$7,429|15,544|



48 



# THE MYTON HOSPICES (A company limited by guarantee) 

## NOTES TO THE FINANCAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024 

## 30. CAPITAL COMMITMENTS 

At 31 March 2024 the Charity had capital commitments for leasehold improvements of £Nil (2023: £90,500). 

49 

